Page 2,007«..1020..2,0062,0072,0082,009..2,0202,030..»

Secondary Progressive MS: Symptoms and Treatment

Posted: Published on July 12th, 2016

People with secondary progressive multiple sclerosis (SPMS) start out with another type of MS -- relapsing-remitting multiple sclerosis. If you've been diagnosed with SPMS you may have had relapsing-remitting MS for a decade or more. That's when you may begin to feel a shift in your disease. The changes are often not easy to recognize. But you may notice that your relapses may not seem to fully go away. Most people with relapsing-remitting MS -- about 80% -- eventually get secondary progressive MS. The relapses and remissions that used to come and go change into symptoms that steadily get worse. The shift typically begins 15 to 20 years after youre first diagnosed with MS. Because multiple sclerosis is such a complex disease, it can be hard to spot the changes that signal SPMS, even for health professionals. Doctors often wait at least 6 months before they diagnose SPMS. Relapsing-remitting MS can be unpredictable, but theres usually a pattern of clear attacks followed by times of recovery. With SPMS, relapses tend to be less distinct. They may happen less often or not at all. When you do have relapses, recovery is not as complete. Along with these signs, there are other … Continue reading →

Posted in MS Treatment | Comments Off on Secondary Progressive MS: Symptoms and Treatment

Alternative Treatment for MS: Click for Options & Medicine

Posted: Published on July 12th, 2016

Alternative treatment (CAM) for MS facts CAM (complementary and alternative medicine) is care provided in addition (integrative medicine) to or instead of traditional or standard medical practices. This group of therapies is wide-ranging, and includes: Some people who seek out alternative medicine feel that conventional therapy has not successfully controlled their symptoms, or that the potential side effects associated with traditional therapy aren't acceptable. Others find that adding complementary medicine to their program allows improved control of symptoms. When complementary medicine is added to traditional routes, it is referred to as integrative medicine. Recent studies through the US Centers for Disease Control and Prevention (CDC), specifically the National Health Interview Survey, suggest that as many as 38% of residents within the United States seek out CAM. Many therapies that are considered within the group of complementary and alternative medicines haven't been studied extensively or investigated in comparison to conventional treatment options. Multiple sclerosis (MS) is a disease that causes demyelination of the brain and spinal cord, or a loss of the covering around axons. When this occurs, the axons (the parts of the nerve cells that transmit impulses to other cells) don't work well. As more areas of the central … Continue reading →

Posted in MS Treatment | Comments Off on Alternative Treatment for MS: Click for Options & Medicine

Parkinson’s disease – Treatment – NHS Choices

Posted: Published on July 12th, 2016

Medicationcan be used toimprove the main symptoms of Parkinsons disease, such as tremors (uncontrollable shaking) and movement problems. However, not all the medications available are useful for everyone, and the short and long-term effects of each are different. Three main types of medication are commonly used. These are levodopa, dopamine agonists and monoamine oxidase-B inhibitors Your specialist can explain your medication options, including the risks associated with each medication, and discuss which may be best for you. Regular reviews will be required as the condition progresses and your needs change. Read on to learn about the treatments you may be offered. You can also see a summary of the pros and cons of treatments for Parkinson's disease, where you can compare your options. Most people with Parkinson's disease will eventually need to have a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. Increasing the levels of dopamine using levodopa usually improves movement problems. Levodopa is usually taken as a tablet or liquid and is often combined with other medication, such as benserazide … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Parkinson’s disease – Treatment – NHS Choices

Cell and Stem Cell Conferences | Exhibitions | Worldwide …

Posted: Published on July 12th, 2016

OMICS International Conferences invites all the participants from all over the world to attend '6th World Congress on Cell & Stem Cell Research during February 29-March 02, 2016 in Philadelphia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions Track01:Stem Cell The most well-established and widely used stem cell treatment is thetransplantationof blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. Since the 1970s,skin stem cellshave been used to grow skin grafts for patients with severe burns on very large areas of the body. Only a few clinical centers are able to carry out this treatment and it is usually reserved for patients with life-threatening burns. It is also not a perfect solution: the new skin has no hair follicles or sweat glands. Research aimed at improving the technique is ongoing. Related Conferences: International Conference on Pancreatic andColorectal Cancer, March 29-30, 2016, Atlanta, USA; International Conference onProstate Cancerand Treatment, May 5-7, 2016, Chicago, USA;Cancer DiagnosticsConference & Expo, June 13-15, 2016, Rome, Italy; International Conference onTissue Scienceand Regenerative Medicine, Sept 12-14, 2016, Berlin Germany;Gene Regulatory Networks and the Encoded Causality of Development, … Continue reading →

Posted in Stem Cell Research | Comments Off on Cell and Stem Cell Conferences | Exhibitions | Worldwide …

ARTICLE IN PRESS – Nanomedicine

Posted: Published on July 12th, 2016

%PDF-1.4 % 137 0 obj > endobj xref 137 134 0000000016 00000 n 0000003032 00000 n 0000003226 00000 n 0000003265 00000 n 0000003324 00000 n 0000004124 00000 n 0000004935 00000 n 0000005002 00000 n 0000005146 00000 n 0000005264 00000 n 0000005353 00000 n 0000005413 00000 n 0000005523 00000 n 0000005583 00000 n 0000005703 00000 n 0000005870 00000 n 0000005930 00000 n 0000006083 00000 n 0000006190 00000 n 0000006315 00000 n 0000006437 00000 n 0000006496 00000 n 0000006605 00000 n 0000006699 00000 n 0000006759 00000 n 0000006882 00000 n 0000006942 00000 n 0000007067 00000 n 0000007183 00000 n 0000007243 00000 n 0000007363 00000 n 0000007488 00000 n 0000007548 00000 n 0000007666 00000 n 0000007726 00000 n 0000007836 00000 n 0000007895 00000 n 0000008048 00000 n 0000008201 00000 n 0000008352 00000 n 0000008504 00000 n 0000008657 00000 n 0000008810 00000 n 0000008963 00000 n 0000009113 00000 n 0000009265 00000 n 0000009418 00000 n 0000009571 00000 n 0000009723 00000 n 0000009819 00000 n 0000009914 00000 n 0000010010 00000 n 0000010106 00000 n 0000010203 00000 n 0000010300 00000 n 0000010396 00000 n 0000010491 00000 n 0000010588 00000 n 0000010684 00000 n 0000010778 00000 n 0000010870 00000 n 0000010964 00000 n 0000011058 00000 n 0000011153 … Continue reading →

Comments Off on ARTICLE IN PRESS – Nanomedicine

Femtocell – Wikipedia, the free encyclopedia

Posted: Published on July 12th, 2016

In telecommunications, a femtocell is a small, low-power cellular base station, typically designed for use in a home or small business. A broader term which is more widespread in the industry is small cell, with femtocell as a subset. It connects to the service providers network via broadband (such as DSL or cable); current designs typically support four to eight active mobile phones in a residential setting depending on version number, and eight to 16 active mobile phones in enterprise settings. A femtocell allows service providers to extend service coverage indoors or at the cell edge, especially where access would otherwise be limited or unavailable. Although much attention is focused on WCDMA, the concept is applicable to all standards, including GSM, CDMA2000, TD-SCDMA, WiMAX and LTE solutions. Use of femtocells benefits both the mobile operator and the consumer. For a mobile operator, the attractions of a femtocell are improvements to both coverage, especially indoors, and capacity. Coverage is improved because femtocells can fill in the gaps and eliminate loss of signal through buildings. Capacity is improved by a reduction in the number of phones attempting to use the main network cells and by the off-load of traffic through the user's … Continue reading →

Posted in Femtomedicine | Comments Off on Femtocell – Wikipedia, the free encyclopedia

Embryonic stem cell research: an ethical dilemma | Europe’s …

Posted: Published on July 12th, 2016

A human embryo can split into twins or triplets until about 14 days after fertilization Egg and sperm: some people believe an embryo must be fully protected from conception onwards (Wellcome Images/Spike Walker) Human blastocyst on the tip of a pin: embryonic stem cells can be grown from cells found in the blastocyst (Wellcome Images/Yorgos Nikas) Some people think an embryo deserves special protection from about 14 days after fertilization Many patients could one day benefit from embryonic stem cell research The rules controlling embryonic stem cell research vary around the world and have been the topic of much discussion Embryonic stem cell research poses a moral dilemma. It forces us to choose between two moral principles: In the case of embryonic stem cell research, it is impossible to respect both moral principles.To obtain embryonic stem cells, the early embryo has to be destroyed. This means destroying a potential human life. But embryonic stem cell research could lead to the discovery of new medical treatments that would alleviate the suffering of many people. So which moral principle should have the upper hand in this situation? The answer hinges on how we view the embryo. Does it have the status of … Continue reading →

Posted in Stem Cell Research | Comments Off on Embryonic stem cell research: an ethical dilemma | Europe’s …

Miami Stem Cell Treatment Center

Posted: Published on July 12th, 2016

The Advancement of Stem Cell Technology At the Miami Stem Cell Treatment Center we provide consultation relating to clinical research and deployment of stem cell therapy for patients suffering from diseases that may have limited treatment options. Stem cell therapy is not for everyone but under the right circumstances and under the right conditions there may be an opportunity for stem cell therapy to be effective. But stem cell therapy is not, at present time, is not the holy grail we all would like it to be. Our expertise involves a deep commitment and long-term understanding, knowledge and experience in clinical research and the advancement of regenerative medicine. We firmly support respected guidance regarding stem cell therapy indicating that it should be autologous, include ONLY minimal manipulation of regenerative cells, and be consistent with homologous use. We do NOT advise the addition of chemicals or enzymes to produce the stromal vascular fraction (SVF). We believe that treatment protocols ought to be reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection (OHRP) or United States F.D.A, or both. Because we are committed to the principles and ideals … Continue reading →

Comments Off on Miami Stem Cell Treatment Center

Nanomedicine Awards 2015

Posted: Published on July 12th, 2016

The 2nd edition of the Nanomedicine Award aims to reward projects that have developed innovative solutions based on nanomedicine that can ultimately change the way diseases are treated or diagnosed and that could provide new tools for physicians and large benefits to patients. Open to companies, academic and private researchers from European and non-European countries, the Nanomedicine Award aims to honor the best international nanomedicine innovations. Proposals will be evaluated in two areas: Early clinical stage project Award and Best product / deal Award for application in diagnostic, therapeutic or regenerative medicine. All applications will be reviewed and assessed by a panel of highly-qualified pharma industry specialists with experience in R&D and commercial roles. The reviewers are: The European Technology Platform for Nanomedicine (ETPN) together with an EU funded consortium named ENATRANS are organizing the second edition of the Nanomedicine Award. Further information can be found here and on the ETPN website The Nanomedicine Award is supported by EBD Group and the award ceremony will take place during BIO-Europe 2015. The 21th annual BIO-Europe event will be the largest biotechnology partnering conference held in Europe. Over 3,200 international decision makers from biotech, pharma and finance along with the most promising … Continue reading →

Comments Off on Nanomedicine Awards 2015

Dietary treatment of gluten ataxia — Hadjivassiliou et al …

Posted: Published on July 12th, 2016

Background: Gluten ataxia is an immune mediated disease, part of the spectrum of gluten sensitivity, and accounts for up to 40% of cases of idiopathic sporadic ataxia. No systematic study of the effect of gluten-free diet on gluten ataxia has ever been undertaken. Objective: To study the effect of gluten-free diet on patients presenting with ataxia caused by gluten sensitivity. Methods: 43 patients with gluten ataxia were studied. All were offered a gluten-free diet and monitored every six months. All patients underwent a battery of tests to assess their ataxia at baseline and after one year on diet. Twenty six patients (treatment group) adhered to the gluten-free diet and had evidence of elimination of antigliadin antibodies by one year. Fourteen patients refused the diet (control group). Three patients had persistently raised antigliadin antibodies despite adherence to the diet and were therefore excluded from the analysis. Results: After one year there was improvement in ataxia reflected in all of the ataxia tests in the treatment group. This was significant when compared with the control group. The diet associated improvement was apparent irrespective of the presence of an enteropathy. Conclusions: Gluten ataxia responds to a strict gluten-free diet even in the absence … Continue reading →

Comments Off on Dietary treatment of gluten ataxia — Hadjivassiliou et al …

Page 2,007«..1020..2,0062,0072,0082,009..2,0202,030..»